Zimmer Biomet Holdings Inc. (ZBH) News
Filter ZBH News Items
ZBH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ZBH News Highlights
- For ZBH, its 30 day story count is now at 11.
- Over the past 24 days, the trend for ZBH's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- The most mentioned tickers in articles about ZBH are TOP, TREE and UGI.
Latest ZBH News From Around the Web
Below are the latest news stories about ZIMMER BIOMET HOLDINGS INC that investors may wish to consider to help them evaluate ZBH as an investment opportunity.
Are Zimmer Biomet Holdings, Inc.'s (NYSE:ZBH) Mixed Financials Driving The Negative Sentiment?It is hard to get excited after looking at Zimmer Biomet Holdings' (NYSE:ZBH) recent performance, when its stock has... |
Why This 1 Value Stock Could Be a Great Addition to Your PortfolioWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle — And Shares SoarDexcom stock surged Wednesday after the company allayed concerns that popular weight-loss drugs would tamp on its diabetes devices. |
Is Zimmer Biomet Holdings (ZBH) Modestly Undervalued? A Comprehensive AnalysisDelving into the intrinsic value of Zimmer Biomet Holdings (ZBH) based on its financial performance and market position |
Zimmer Biomet Announces Key Updates to Company's Executive Leadership TeamZimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced key updates to the Company's Executive Leadership Team. Wilfred van Zuilen has been promoted to Group President, EMEA; Mark Bezjak was promoted to President of the Americas; and Chief Science, Technology and Innovation Officer Nitin Goyal, M.D. has been appointed to the Executive Leadership Team, all reporting directly to President and Chief Executive Officer Ivan Tornos. |
Zimmer Biomet (ZBH) Business Recovery Continues Despite FX WoeZimmer Biomet (ZBH) is benefiting from increased provider capacity, resulting in backlog pull-through in the recent quarters. |
Bearish Bets: 3 Stocks You Absolutely Should Think About Shorting This WeekUsing technical analysis of the charts of those stocks, and, when appropriate, recent actions and grades from TheStreet's Quant Ratings, we zero in on three names. While we will not be weighing in with fundamental analysis, we hope this piece will give investors interested in stocks on the way down a good starting point to do further homework on the names. Dollar Tree Inc. recently was downgraded to Hold with a C+ rating by TheStreet's Quant Ratings. |
Here's Why You Should Retain Zimmer Biomet (ZBH) for NowInvestors are optimistic about Zimmer Biomet (ZBH) due to innovative new product launches and solid execution. |
Nvidia upgraded, CrowdStrike downgraded: Wall Street's top analyst callsNvidia upgraded, CrowdStrike downgraded: Wall Street's top analyst calls |
5 big analyst picks & cuts: Morgan Stanley trims CrowdStrike ahead of Q2Here is your Pro Recap of the biggest analyst picks and cuts you may have missed today: upgrades at Forward Air, Zimmer Biomet, and UGI, and downgrades at CrowdStrike and L3Harris Technologies. Crowdstrike (NASDAQ:CRWD) shares fell more than 2% premarket today after Morgan Stanley downgraded the company to Equalweight from Overweight and cut its price target to $167.00 from $178.00 ahead of Q2/24 earnings announcement on Wednesday. Morgan Stanley believes that the consensus forecast for NNARR is overly optimistic at 6% year-over-year growth in Q3 and sees a downside to a 12% growth estimate in Q4. |